会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明公开
    • 동맥경화 예방 또는 치료용 약제학적 조성물
    • 用于预防或治疗肠梗塞的药物组合物
    • KR1020130103901A
    • 2013-09-25
    • KR1020120024903
    • 2012-03-12
    • 아이진 주식회사
    • 조양제장진욱임형준
    • A61K38/16A61K38/17A61P9/10A61P9/00
    • C07K14/00A61K38/17
    • PURPOSE: A pharmaceutical composition for preventing or treating arteriosclerosis is provided to effectively reduce the formation of atherosclerotic plaques without toxicity to the liver and kidney, thereby effectively treating arteriosclerosis. CONSTITUTION: A pharmaceutical composition for preventing or treating arteriosclerosis contains pharmaceutically effective amount of proteins containing an amino acid of sequence number 1; and a pharmaceutically acceptable carrier. The arteriosclerosis is atherosclerosis, medial calcific sclerosis, or arteriolosclerosis. The arteriosclerosis is developed in a patient with an apolipoprotein E gene deficiency.
    • 目的:提供用于预防或治疗动脉硬化的药物组合物,以有效地减少动脉粥样硬化斑块的形成,而不会对肝脏和肾脏产生毒性,从而有效治疗动脉硬化。 构成:用于预防或治疗动脉硬化的药物组合物含有药学有效量的含有序列号1的氨基酸的蛋白质; 和药学上可接受的载体。 动脉硬化是动脉粥样硬化,内侧钙化硬化或动脉硬化。 在患有载脂蛋白E基因缺陷的患者中发展动脉硬化。
    • 7. 发明公开
    • 안지오포이에틴 분비 유발 폴리펩타이드
    • 多糖诱导安非他酮的分泌
    • KR1020070011371A
    • 2007-01-24
    • KR1020067021091
    • 2004-03-31
    • 아이진 주식회사
    • 조양제안보영김두식유원일
    • C07K14/515A61K38/00
    • A polypeptide is provided to be able to induce the secretion of angiopoietin, thereby being used as a therapeutic agent to facilitate a formation of a normal structure of blood vessel. The protein for inducing an angiopoietin-1 secretion comprises an amino acid sequence described in SEQ ID NO 1. The therapeutic agent for treating angiogenesis-related diseases such as pulmonary hypertension, ischemic myocardium, skin flap survival, heart failure, acute hindlimb ischemia and ocular diseases comprises an effective amount of the angiopoietin-1 secretion-inducing proteins comprising the protein of SEQ ID NO 1.
    • 提供多肽以能够诱导血管生成素的分泌,由此用作治疗剂以促进血管的正常结构的形成。 用于诱导血管生成素-1分泌的蛋白质包含SEQ ID NO 1中所述的氨基酸序列。用于治疗血管生成相关疾病如肺动脉高压,缺血心肌,皮瓣存活,心力衰竭,急性后肢缺血和眼睛的治疗剂 疾病包括有效量的包含SEQ ID NO 1的蛋白质的血管生成素-1分泌诱导蛋白。